CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			47,556,267
Beginning balance	$ (126,116)	$ (149,552)	$ (130,328)	$ (58,995)
Issuance of common stock in connection with settlement of Series H convertible preferred stock				12,000
Issuance of common stock for restricted stock units		0		0
Common stock withheld for taxes	$ (12)	$ (7)	$ (16)	$ (486)
Repurchase of common stock for Fexy put option (in shares)	(2,061)	(8,606)	(4,875)	(290,777)
Repurchase of common stock for Fexy put option				$ (379)
Stock-based compensation	$ 161	$ 545	$ 357	2,204
Net income (loss)	108,639	(8,187)	112,659	(111,545)
Ending balance	$ (17,328)	$ (157,201)	$ (17,328)	$ (157,201)
Ending balance (in shares)	47,564,607		47,564,607
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	47,560,952	29,513,563	47,556,267	23,836,706
Beginning balance	$ 475	$ 294	$ 475	$ 237
Issuance of common stock in connection with settlement of Series H convertible preferred stock (in shares)				5,555,555
Issuance of common stock in connection with settlement of Series H convertible preferred stock				$ 56
Issuance of common stock for restricted stock units (in shares)	4,999	68,975	12,498	747,140
Issuance of common stock for restricted stock units		$ 1		$ 8
Common stock withheld for taxes, (in shares)	(2,061)	(8,606)	(4,875)	(290,777)
Common stock withheld for taxes				$ (3)
Issuance of common stock in connection with the exercise of stock options (in shares)	717		717
Repurchase of common stock for Fexy put option (in shares)				(274,692)
Repurchase of common stock for Fexy put option				$ (3)
Ending balance	$ 475	$ 295	$ 475	$ 295
Ending balance (in shares)	47,564,607	29,573,932	47,564,607	29,573,932
Common To Be Issued
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	2,701	2,701	2,701	2,701
Beginning balance	$ 0	$ 0	$ 0	$ 0
Ending balance	$ 0	$ 0	$ 0	$ 0
Ending balance (in shares)	2,701	2,701	2,701	2,701
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	$ 348,752	$ 332,165	$ 348,560	$ 319,421
Issuance of common stock in connection with settlement of Series H convertible preferred stock				11,944
Issuance of common stock for restricted stock units		(1)		(8)
Common stock withheld for taxes	(12)	(7)	(16)	(483)
Repurchase of common stock for Fexy put option				(376)
Stock-based compensation	161	545	357	2,204
Ending balance	348,901	332,702	348,901	332,702
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(475,343)	(482,011)	(479,363)	(378,653)
Net income (loss)	108,639	(8,187)	112,659	(111,545)
Ending balance	$ (366,704)	$ (490,198)	$ (366,704)	$ (490,198)